Estrogen is a key regulator in the development of the female reproductive system. It also stimulates oviduct development in immature chicks. We identified candidate genes and pathways associated with the development of chicken oviducts. A pellet containing the synthetic estrogen analog diethylstilbestrol (DES) was implanted subcutaneously in 1-wk-old female chicks for 10 days. The pellet was removed from half the group for 10 days, and an additional dose was given for a further 10 days. Total RNA was extracted from the oviducts of DES-treated and untreated chicks and subjected to an Affymetrix chicken GeneChip analysis. We found differential expression of 2290 and 1745 transcripts from the oviducts that were treated with DES once and twice, respectively. We also found a twofold or greater change in the expression of 77 and 390 transcripts between the two control and DES-treated time points, respectively, while we found a change in the expression of 10 transcripts that were common to all groups. Analyses of real-time PCR and in situ hybridization of selected genes confirmed the validity of the gene expression patterns observed in the microarray analysis. In particular, CCRN4L, FAM26F, HAS2, NELF, and NTM were upregulated in the DES-treated chicken oviducts. High-throughput analysis revealed that the differentially expressed genes were related to tubular formation, epithelial differentiation, hormone interactions, nerve development, and tissue remodeling in the chicken oviduct. This study provides novel insights into candidate genes regulating oviduct development and differentiation via estrogen. The identified genes may serve as biomarkers of reproductive tract development in chicks.
INTRODUCTION
Estrogen has diverse roles in biological processes. It regulates the development and differentiation of germ cells and their niches [1, 2] , controls reproductive tract development and function [3] , and is involved in bone homeostasis [4] . The physiological behavior of estrogen is mediated by its nuclear receptors, estrogen receptors alpha (ESR1) and beta (ESR2) [5] . ESRs drive physiological changes by regulating different transcription factors and target genes.
The chicken oviduct is an excellent model for studying hormonal action [6] and can be used as a bioreactor for therapeutic protein production [7] . Most studies of estrogenmediated oviduct development have investigated the phenomena and developmental status of folliculogenesis and egg production. Estrogen controls the growth of the preovulatory follicle and yolk production in the liver [8, 9] and is involved in calcium metabolism for eggshell formation and ovipositioning [10, 11] . It is also essential in stimulating the development of and maintaining the function of chicken oviducts [6, 12] . Additionally, estrogen triggers the formation of tubular glands and epithelium differentiation into goblet and ciliated cells in the oviduct [13] . Moreover, estrogen exposure induces the synthesis of egg white protein, including ovalbumin, conalbumin, ovomucoid, and lysozyme, in the oviducts of hatched chicks [14] .
Since the chicken genome was sequenced, high-throughput analysis using the chicken DNA microarray technique has become available in order to study genes expressed in specific specimens from chick tissues. Yang et al. [15] identified 85 differentially expressed transcripts in the shell glands for comparing poor and superb layer strains using microarray analysis. More recently, Dunn et al. [16] identified 266 differentially expressed genes in the shell glands of juvenile and mature hens. These results contribute to understanding the unique functions of eggshells, including antimicrobial activity.
We examined transcript changes in chick oviducts after exposure to diethylstilbestrol (DES). DES is a nonsteroidal, synthetic estrogen that binds strongly to estrogen receptors, with effects similar to natural estrogen 17b-estradiol [6, 17, 18] . Through microarray analysis, we identified genes that showed significant changes during oviduct development. To validate our microarray data, we first selected many egg white protein genes such as ovalbumin, ovomucoid, lysozyme, hep21, SERPINB1 (ovalbumin X), and SERPIN14B (ovalbumin Y); eggshell-specific genes such as ovocalyxin 36, ovocleidin 116, and retinoic acid receptor responder (tazaroten induced) 1 (previously ovocalyxin 32); and several other genes, including the five genes for real-time PCR analyses. The results showed that most of the genes were greatly increased in developing chick oviduct by DES treatment, as previously reported. Therefore, we mainly focused on the five genes that are least well-known in chick oviduct development and also those most up-regulated by DES treatment. Furthermore, we will investigate the regulation and function of the five genes dependent on estrogen in oviduct growth and development.
Collectively, the results provide new insights into the hormonal regulation of differentiation genes required in chicken oviduct development.
MATERIAL AND METHODS

Experimental Animals and Animal Care
The experimental use of chickens was approved by the Institute of Laboratory Animal Resources, Seoul National University (SNU-070823-5). White Leghorn chickens were managed following a standard program at the University Animal Farm, Seoul National University, Korea. The management, reproduction, and embryo manipulation procedures adhered to the standard operating protocols of our laboratory. All chickens were given access to feed and water ad libitum.
DES Treatment and Oviduct Retrieval
Female chicks were selected by PCR analysis using the W chromosomespecific primer sets described [19] . DES treatment and oviduct retrieval were conducted as reported previously [12, 20] . Briefly, a 15-mg DES pellet was implanted subcutaneously in the abdominal region of 1-wk-old female chicks for 10 days. The DES pellet was removed from half the chicks for 10 days, and a 30-mg dose was administered for 10 more days [12] . Oviducts were removed from chicks that had received the single pellet (designated T1, 17 days old) or repeated pellets (designated T2, 37 days old) and analyzed. Oviducts from untreated chicks the same ages (C1 and C2) as T1 and T2 were used as controls. Five chicks in each group were euthanized using 60%-70% carbon dioxide.
Microarray Analysis
Microarray analysis was performed using Affymetrix GeneChip Chicken Genome Arrays (Affymetrix, Santa Clara, CA). Data were generated by SeouLin Bioscience Corporation (Seoul, Korea), and the dChip software was used for the analysis [21] . Because oviducts from the control chicks were very small, a total of nine oviducts derived from control chicks were pooled into three control samples, whereas oviducts from three DES-treated chicks were large enough to be analyzed individually. For biological replication, total RNA was individually extracted from three pooled oviducts from control chicks and three oviducts from DES-treated chicks using TRIzol (Invitrogen, Carlsbad, CA) and purified using an RNeasy Mini Kit (Qiagen, Valencia, CA). We selected differentially expressed genes at each time point by two-sample comparisons, with a lower threshold of greater than a twofold change, a 90% confidence interval, and a group mean difference greater than 100. Differentially regulated genes identified in the microarray analyses were analyzed using the Ingenuity Pathways Analysis (IPA) software (Ingenuity Systems, Mountain View, CA). Canonical pathway analyses identified the pathways from the IPA library of canonical pathways that were most highly represented in the data set.
Quantitative RT-PCR Analysis
Total RNA was extracted from each oviduct of control and DES-treated chicks using TRIzol (Invitrogen) and purified using an RNeasy Mini Kit (Qiagen). Complementary DNA was synthesized using a Superscript III FirstStrand Synthesis System (Invitrogen). Gene expression levels were measured using SYBR Green (Biotium, Hayward, CA) and a StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA). The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was simultaneously analyzed as a control and used for normalization. Each target gene and GAPDH was analyzed in triplicate. Using the standard curve method, we determined the expression quantities of the examined genes using the standard curves and Ct values and normalized them using GAPDH expression quantities. The PCR conditions were as follows: 948C for 3 min, followed by 40 cycles at 948C for 20 sec, 608C for 40 sec, and 728C for 1 min using a melting-curve program (increasing the temperature from 558C to 958C at a rate of 0.58C per 10 sec) and continuous fluorescence measurement. ROX dye (Invitrogen) was used as a negative control for the fluorescence measurements. Sequence-specific products were identified by generating a melting curve in which the Ct value represented the cycle number at which a fluorescent signal rose statistically above background, and relative gene expression was quantified using the 2 -DD Ct method [22] . For the control, the relative quantification of gene expression was normalized to the Ct of the control oviduct. Information on the primer sets is provided in Supplemental Table S1 (available at www.biolreprod.org).
In Situ Hybridization Analysis
The expression of selected genes was examined using in situ hybridization, as described [23] . For hybridization probes, PCR products were generated from cDNA (primers listed in Supplemental Table S2 , available at www.biolreprod. org).The products were gel extracted and cloned into a pGEM-T Easy Vector (Promega, Madison, WI). After sequence verification, a DIG-labeled RNA probe was prepared using a DIG RNA Labeling kit (Roche Applied Science, Indianapolis, IN). Frozen 10-lm sections were mounted on 3-aminopropyltriethoxysilane (Sigma, St. Louis, MO)-pretreated slides, dried on a 508C slide warmer, and fixed in 4% paraformaldehyde in PBS. The sections were treated with 1% Triton X-100 in PBS for 20 min and washed three times in PBS. The sections were incubated in a prehybridization mixture containing 50% formamide and 53 standard saline citrate (SSC) for 15 min at room temperature. The sections were then incubated with a hybridization mixture containing 50% formamide, 53 SSC, 10% dextran sulfate sodium salt, 0.02% bovine serum albumin, 250 lg/ml yeast tRNA, and denatured DIG-labeled cRNA probes for 18 h at 558C in a humidification chamber. The sections were washed for stringency in a series of solutions containing 50% formamide and downgrades of SSC (53 SSC for 15 min, 23 SSC for 30 min, and 0.23 SSC for 60 min) at 558C. After blocking with 1% blocking reagent (Roche) in a buffer containing 1 M Tris-HCl (pH 7.5) and 2.5 M NaCl, the sections were incubated at 48C overnight with sheep anti-DIG antibody (1:5000 in 1% blocking reagent) conjugated to alkaline phosphatase (Roche). The signal was visualized after exposure to a visualization solution containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate, 0.4 mM nitroblue tetrazolium, and 2 mM levamisole (Sigma). All sections were counterstained with 1% (w/v) methyl green (Sigma), and photographs were taken using a Zeiss Axiophot light microscope equipped with an AxioCam HRc camera (Carl Zeiss, Oberkochen, Germany).
Statistical Analyses
Data for quantitative RT-PCR were subjected to ANOVA according to the general linear model (PROC-GLM) of the SAS program (SAS Institute, Cary, NC) to determine whether treatment effects were significant. Data presented for real-time PCR are mean 6 SEM unless otherwise stated. Differences in the variance between control and DES-treated oviducts ( Fig. 1) were analyzed using the F-test, and differences in the means were subjected to the Student ttest. P , 0.05 was considered statistically significant. Excel (Microsoft, Redmond, WA) was used for statistical analyses.
RESULTS
Effects of DES Treatment on Chick Oviduct Development
We previously reported that exogenous administration of DES affected growth and differentiation in chicken oviduct development ( Fig. 1 ) [12] . In summary, immature oviducts treated with DES were morphologically differentiated into the infundibulum, magnum, isthmus, and shell gland (uterus), and physiologically normal amounts of white egg proteins were produced from well-developed tubular gland cells. After DES stimulation, the wet weight and length of T1 oviducts increased by 29-fold (32.7 6 0.23 mg versus 961 6 60.7 mg; P , 0.01) and 2.7-fold (3.07 6 0.40 cm versus 8.43 6 1.01 cm; P , 0.01), respectively, and those of T2 oviducts increased by about 74-fold (49.6 6 5.1 mg versus 3665 6 469 mg; P , 0.01) and 4.5-fold (3.73 6 0.42 cm versus 16.8 6 3.2 cm; P , 0.01), respectively [12] .
Oviduct Gene Expression Is Altered by DES Treatment in Young Chicks
Oviducts from T1 and T2 stimulated with DES had better developed tubular glands in which egg white proteins were produced compared with control groups C1 and C2, in agreement with our previous results [12] . Microarray analysis identified differences in oviduct transcriptomes between the controls and DES treatments ( Tables S3-S6 [available at www.biolreprod. org]). Clustering analysis of genes changed significantly in the four comparisons described above (Fig. 2B) . Additionally, genes co-regulated in C1 versus T1 and C2 versus T2 and in C1 versus C2 and T1 versus T2 are presented as Venn diagrams (Fig. 2, C and D) .
Validation of Selected Genes
A quantitative RT-PCR analysis was performed to validate the effects of DES on selected genes from the microarray analyses, including carbon catabolite repression 4-like (CCRN4L), family with sequence similarity 26, member F (FAM26F), hyaluronan synthase 2 (HAS2), nasal embryonic LHRH factor (NELF), and neurotrimin (NTM), in DES-treated and untreated oviducts. CCRN4L and HAS2 mRNA levels were unaffected between C1 and T1 (P . 0.05, respectively) but increased between C2 and T2 (P , 0.001, respectively; Fig. 3) . FAM26F, NELF, and NTM mRNA levels increased significantly between C1 and T1 (P , 0.005, respectively) and C2 and T2 (P , 0.0001, respectively). The change in the expression levels of the five genes revealed by quantitative RT-PCR analysis was consistent with that by microarray analysis ( Table 1 ). The mRNA of the selected genes from oviduct tissues was localized by in situ hybridization analysis. As expected, cell-specific differences in the expression of the validated genes were observed within the chicken oviduct (Fig.  4) . FAM26F and NTM expression levels were detected at weak/ basal levels in the C2 oviducts. All mRNA was localized predominantly in the glandular epithelium and, to a lesser extent, the luminal epithelium of the chicken oviduct.
Functional Categorization of Significantly Regulated Genes During Chicken Oviduct Development by DES Treatment
Between C1 and T1, C2 and T2, C1 and C2, and T1 and T2, some genes involved in biological and developmental processes changed, such as the physiological response to stimuli and the response to biological stimuli of the oviduct. In both the single and repeated DES treatments, genes related to small-molecule biochemistry, lipid metabolism, molecular transport, amino acid metabolism, and vitamin and mineral metabolism in molecular and cellular functions were altered ( Fig. 5A and Supplemental Table S7 [available at www. biolreprod.org]). As categorized by physiological system development and function, genes are associated with nervous system development and function, endocrine system development and function, embryonic development, reproductive system development and function, and organ development ( Fig. 5B and Supplemental Table S7 [available at www. biolreprod.org]). In the single DES treatment, genes changed primarily related to cellular growth and proliferation, organism development in molecular and cellular function, and physiological system development and function, respectively (Fig. 5 , C and D, and Supplemental Table S8 [available at www. biolreprod.org]). In the double DES treatment, genes that changed were related to cellular development, growth, proliferation, and death in molecular and cellular functions, hematological system development and function, and hematopoiesis in physiological system development and function, respectively (Fig. 5 , E and F, Supplemental Table S9 , [available at www.biolreprod.org]). Gene ontology analysis also revealed the presence of genes enriched in endocrine and reproductive system development in T1 and T2 oviducts (Tables 2-4) . 
the oviduct after primary (T1) and secondary (T2) DES treatments. Bar ¼ 1 cm. B) Wet weight of oviducts after primary (T1) and secondary (T2) DES treatments (mean 6 SEM, n ¼ 5). C) Length of oviduct after primary (T1) and secondary (T2) DES treatments (mean 6 SEM, n ¼ 5). D) Body weight of chicks after primary (T1) and secondary (T2) DES treatments (mean 6 SEM, n ¼ 5). *P , 0.05 (significant differences between control and treated chicks). IF, infundibulum; MA, magnum; IS, isthmus; SG, shell gland; C1, Control 1 (17-day-old chick oviduct, untreated); T1, Treatment 1 (17-day-old chick oviduct treated with primary DES for 10 days); C2, Control 2 (37-day-old chick oviduct, untreated); T2, Treatment 2 (37-day-old chick oviduct treated with secondary DES for 10 days, after 10 days of primary DES treatment followed by 10 days of withdrawal of DES). Adapted from Seo et al. [12] with permission from the Journal of Animal Science and Technology.
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DISCUSSION
In the present study, transcriptional profiling of the chicken oviduct model of early estrogen-accelerated oviduct development identified candidate genes that potentially regulate the growth, development, and differentiation of female reproductive tracts. As illustrated in Figure 1 , we previously reported that exogenous administration of DES affected growth and differentiation in chicken oviduct development. Therefore, genes that increased or decreased between control and DEStreated groups are likely to be important for the developmental mechanism(s) of early chick oviducts by hormone responsiveness. Our current microarray analysis showed at least a twofold difference in 2290 genes between C1 and T1 (896 genes were up-regulated and 1394 genes were down-regulated) as well as in 1745 genes between C2 and T2 (645 genes were up-
A) The number of genes for which expression significantly increased or decreased after single (T1) and repeated (T2) DES treatment in chick oviducts. Differentially expressed genes were selected using a two-sample comparison according to the following criteria: lower bound of 90% confidence interval of fold-change greater than 2.0 and an absolute value of difference between groups means greater than 100. Values in parentheses indicate total genes changed in each comparison. B) Clustering analysis of genes significantly changed in the four comparisons (C1 versus T1, C2 versus T2, C1 versus C2, T1 versus T2). C and D) The relationship between genes modulated in the DES treatment (C) and age (D). The numbers displayed within the intersections of the circles indicate the common genes by the two comparisons. regulated and 1100 genes were down-regulated). Between time points in both control and treated chicks, twofold differences were evident in 77 genes between C1 and C2 (31 genes were up-regulated and 46 genes were down-regulated) and in 390 genes between T1 and T2 (312 genes were up-regulated and 78 genes were down-regulated). A comprehensive discussion of all the genes in the oviduct affected by DES treatment is not possible. Therefore, the discussion will focus on five interrelated genes that likely form a physiological network important for oviduct growth and function in chickens, with insights from other mammals, and that were well validated by quantitative RT-PCR and in situ hybridization analyses consistent with microarray data. Based on the microarray and quantitative PCR analyses, HAS2 and CCRN4L increased in chicks implanted with two DES pellets, whereas NELF increased in chicks treated with both one and two pellets. Similar to deadenylase, CCRN4L removes the poly(A) tails from mRNA [24] and is associated with rhythmic processes in mammalian tissues [25] . The disruption of CCRN4L reveals that this gene is important in systemic metabolic activity because it posttranscriptionally controls various downstream genes necessary for nutrient FIG. 4 . Messenger RNA localization of five genes (CCRN4L, FAM26F, HAS2, NELF, and NTM) related to chicken oviduct development. In situ hybridization analyses of the five selected genes during chicken oviduct development. The mRNA of all five genes was localized predominantly to the glandular epithelium and to a lesser extent the luminal epithelium of the chicken oviductal magnum. LE, luminal epithelium; GE, glandular epithelium; S, stroma. Bar ¼ 10 lm.
FIG. 3.
Comparison of relative mRNA expression of five genes (CCRN4L, FAM26F, HAS2, NELF, and NTM) selected as being significantly changed during chicken oviduct development. Quantitative RT-PCR analyses of the five selected genes during chicken oviduct development. Messenger RNA levels of CCRN4L and HAS2 were unaffected between C1 and T1 (P . 0.05), respectively, but increased between C2 and T2 (P , 0.001), respectively. In contrast, the FAM26F, NELF, and NTM mRNA levels significantly increased between C1 and T1 (P , 0.005), respectively, and between C2 and T2 (P , 0.0001), respectively. Each bar represents the mean 6 SEM of independent experiments (n ¼ 3). The asterisks denote effects that were significant (***P , 0.0001, **P , 0.001, or *P , 0.005). 310 metabolism and maintenance [26] . Though we cannot directly correlate the effect of DES on the expression level of CCRN4L, we cannot reject the possibility that this gene may contribute to energy source regulation, allowing oviduct epithelial cells to proliferate during oviduct development. HAS2 is a protein involved in the synthesis of hyaluronan, or hyaluronic acid, which is a prominent component of the extracellular matrix [27] . It has been suggested that hyaluronan is involved in human endometrium and stroma growth and remodeling in menstrual cycles via supporting cell migration and the provisional matrix [28] . Our data showed increased localization of HAS2 in DES-treated oviducts, similar to the increase in HAS2 in the human endometrium during the midproliferative (Days 5-10) and midsecretory (Days 19-23) phases of the cycle [28] . The role of HAS2 in remodeling oviduct epithelial cells and stroma is likely conserved in various species.
The product of the third gene of interest, NELF, negatively regulates ESR1-mediated transcription by binding to ESR1 directly. Notably, this protein is mobilized to ESR1 by estrogen and subsequently controls the duration and magnitude of estrogen [29] . The substantial increase of NELF found in the DES-treated oviducts supports the idea that regulating ESR1 activity in tubular epithelial cells may affect the function of NELF in the chick oviduct. The interaction between estrogen and other hormones is crucial for the normal function, differentiation, and development of chicken oviducts [6] . Estrogen may moderate nervous system development in chick oviducts. NTM, the fourth gene of interest, regulates sympathetic innervation density in reproductive organs and mediates sympathetic pruning stimulated by estrogen [30] . The expression level of NTM was greatly increased by DES treatment in the microarray and quantitative PCR analyses. Thus, it can be predicted that neuronal precursor and sympathetic innervation development results from single and repeated DES treatments, respectively.
The fifth gene of interest, FAM26F, also known as chromosome 6 open reading frame 187 or hypothetical protein LOC441168, increased in the oviduct of DES-treated chicks; neither this gene expression pattern nor its function have yet been identified. Hence, this is a novel finding of the current study. Therefore, we have attempted to predict the function of FAM26F through the released database for gene expression of unknown genes (Atlas Data or G2SBC database). The G2SBC database shows that Fam26f was identified in cancer microarray studies in various organs of the human body, including the breast, cervix, mammary gland, and uterus [31] . In addition, in Atlas Data, we found that FAM26F expression was associated with immune or defense responses and was especially increased by estradiol treatment in MCF-7 or HeLa cell lines [32] . In our results, its expression increased in the luminal and glandular epithelium regions of developing oviducts by DES treatment. Taken together, we predict that the function of FAM26F is associated with the action of FIG. 5. Functional categorization of the genes that changed during chicken oviduct development. Genes that were changed after both single and repeated DES treatment (A and B) ; genes that changed only after single (C and D) or repeated (E and F) DES treatments. Significantly changed genes were annotated and assigned to various functional categories using gene ontology.
DES-REGULATED GENES AFFECT CHICK OVIDUCT DEVELOPMENT
estrogen within potential target cell growth, proliferation, and differentiation.
In our current study, we also found that transcript changes during oviduct differentiation and development were stimulated by a synthetic estrogen or without treatment through microarray analysis. Although 10 transcripts were commonly identified between C1 and C2 and T1 and T2, they were matched to only five genes, consisting of four up-regulated (IGLL1, CSTA, Gga.5505.1, and IGJ) and one down-regulated (TNFSF15) gene. As illustrated in Figure 2C , because the Reproductive system development and function 312 expression levels of the five genes were commonly altered in C1 versus C2 and T1 versus T2, one assumes that their expression patterns may have been affected by DES treatment as well as by oviduct growth proportional to the age of the chicks. Notably, two of these genes were the immunoglobulin polypeptides immunoglobulin lambda-like polypeptide 1 (IGLL1) and immunoglobulin J polypeptide (IGJ). Although immunoglobulin proteins are mainly produced by plasma B cells, the plasma-like cells secreting the immunoglobulin polypeptides were reportedly localized to the stromal region of chicken oviducts matured by steroid hormones [33, 34] . Because the production of immunoglobulin protein is critical for the egg production and immunity of the oviduct, it may be regulated by estrogen as well as by oviductal cell proliferation and differentiation processes. Furthermore, TNFSF15 is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family and is plentifully produced in endothelial cells. This protein acts as an inhibitor of endothelial cell proliferation by stimulating apoptosis in endothelial cells [35, 36] . Because vascular extension is essential for normal tissue growth, the expression of vascular inhibitors such as TNFSF15 may be associated with oviduct development. Further research is required to fully understand the roles and functions of these genes in the development of the female reproductive tract. This microarray study represents part of a continuing effort to identify candidate genes that regulate chicken oviduct development and differentiation. Moreover, the genes identified in these studies may be useful for studying the development of the chicken reproductive tract and for developing biomarkers in oviduct tissue differentiation. Further analyses of the newly identified genes will help determine their roles during chick oviduct remodeling and will provide an efficient model system for studying the biology of tissuespecific nuclear receptors. 
